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The role of nitric oxide (NO) in the pathogenesis of viral encephalitis was investigated by using an experimental model of
herpes simplex virus type 1 (HSV-1) encephalitis in Lewis rats. The expression of inducible NO synthase (iNOS) mRNA
determined by Northern blotting was observed first in the olfactory bulb and the brain stem on day 5 after intranasal
inoculation of HSV-1, and thereafter iNOS mRNA was detected in other brain regions, i.e., cerebrum and cerebellum. In
various parts of the brain, excessive NO production was identified by electron spin resonance spectroscopy. The temporal
and spatial patterns of iNOS expression coincided with those of viral propagation, as demonstrated by polymerase chain
reaction for HSV-1 gene expression as well as by the plaque-forming assay. Immunohistochemical study determined that
iNOS was localized mainly in monocyte-derived macrophages. Treatment of virus-infected animals with the NOS inhibitor
Nv-monomethyl-L-arginine (L-NMMA), but not Nv-monomethyl-D-arginine, significantly ameliorated not only clinical symptoms
such as paralysis and seizures but also mortality. Virus yield from brain tissue was not affected by L-NMMA treatment. It is
of interest that increased expression of the antioxidant enzyme heme oxygenase-1 was observed in the HSV-1-infected brain;
this increased expression was strongly inhibited by L-NMMA treatment. These data suggest that the high level of NO
produced by iNOS is a pathogenic factor in HSV-1-induced encephalitis in rats. © 1999 Academic Press
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iINTRODUCTION
Nitric oxide (NO) produced in biological systems me-
iates a diverse array of physiological functions (Furch-
ott and Vanhoutte, 1989; Choi, 1993; Moncada and
iggs, 1993). In particular, a large amount of NO gener-
ted by the inducible isoform of nitric oxide synthase
iNOS) has been demonstrated to have a beneficial effect
n host defense mechanisms against bacteria and para-
ites (Granger et al., 1988; Nathan and Hibbs, 1991; Doi
t al., 1993; James, 1995; Umezawa et al., 1997). However,
t has also been shown that NO and its oxidized inter-
ediates such as peroxynitrite cause cytotoxic effects
nd tissue damage and participate in the pathogenesis
f various diseases (Beckman and Koppenol, 1996;
ubbo et al., 1996).
As in bacterial and parasitic infections, iNOS ex-
ression, which brings about overproduction of NO,
as been documented in various viral infections in vivo
Akaike et al., 1998). Although the suppressive effect of
O on virus replication was reported for some viruses
ncluding coxsackievirus (Zaragoza et al., 1997, 1998),
pstein–Barr virus (Mannick et al., 1994), and herpes
implex virus type 1 (HSV-1) (Croen, 1993; Karupiah et
l., 1993; Nathan, 1997; MacLean et al., 1998), it seems
hat excessive NO production is not necessarily ben-
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 81-96-362-8362. E-mail: msmaedah@gpo.kumamoto-v.ac.jp.
203ficial for hosts experimentally infected with a number
f viruses (Akaike et al., 1996, 1998; Kreil and Eibl,
996; Adler et al., 1997). For example, use of NOS
nhibitor to treat mice infected with influenza virus
esulted in amelioration of virus-induced pneumonia,
uggesting that NO produced during the infection is
nvolved in viral pathogenesis. In addition, Adler et al.
1997) reported that suppression of NO biosynthesis
ed to improvement of HSV-1-induced pneumonia in
ice despite moderate impairment of antiviral defense
n the mice.
However, the biological effect of NO in viral patho-
enesis is still unsettled. Furthermore, there are as yet
ew reports that reveal the pathogenic mechanism of
SV-1-induced encephalitis in light of the pathophys-
ological function of NO in vivo. In the present exper-
ment, we investigated the role of NO biosynthesis in
ncephalitis caused by HSV-1 in rats. iNOS expression
nd NO production in each region of the brain were
nalyzed in detail during HSV-1 infection. The patho-
ogical consequence of NO overproduction was exam-
ned by assessing the effect of NOS inhibitor on clin-
cal symptoms and mortality as well as virus growth in
his experimental encephalitis. In addition, the func-
ion of NO was studied in view of heme oxygenase-1
HO-1) induction, which appears to be critically in-
olved in the defense mechanism against various ox-
dative stresses (Maines, 1997). Our present results
ndicate that NO may induce neuronal damage in this
iral encephalitis.
0042-6822/99 $30.00
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204 FUJII, AKAIKE, AND MAEDARESULTS
ropagation of HSV-1 in brain tissue and production
f encephalitis in rats
No apparent clinical symptom due to HSV-1 infection
as observed until 3 days after the Lewis rats were
noculated with 1.0 3 105 PFU (15 50% lethal dose (LD50))
f virus. At 4 to 5 days after virus infection began, all
nimals showed not only nonspecific illness including
lepharostenosis, sanguineous tears, and decreased
otility but also typical clinical signs of neurological
isorders, e.g., paralysis and seizures. Thereafter, the
nimals were highly emaciated, with considerable loss
f body weight. All rats became moribund between 6 and
0 days after infection with this lethal dose of HSV-1.
The time profile of HSV-1 replication in the brain was
nvestigated by using reverse transcriptase-polymerase
hain reaction (RT-PCR) analysis for HSV-1 DNA poly-
erase mRNA as well as plaque-forming assay (Figs. 1A
nd 1B). HSV-1 DNA polymerase mRNA expression and
he infectious virus were not detected in the four regions
f the brain, i.e., olfactory bulb, brain stem, cerebellum,
nd cerebrum, until 4 days after virus inoculation. On day
FIG. 1. Time profile of viral replication in each brain region after HS
A) and by plaque-forming assay (B). At various time points after intra
ontent of each brain region extracted by the guanidine thiocyanate ly
xpression. No apparent PCR product for HSV-1 DNA polymerase was o
ield in each brain region was quantified by using a plaque-forming ass
rain region. Data are means 6 SEM.after infection, the HSV-1 replication was initially iden- iified in the olfactory bulb and the brain stem. Six days
fter the infection began, appreciable levels of virus yield
ere clearly seen in all brain regions. The RT-PCR anal-
sis for HSV-1 DNA polymerase mRNA showed a similar
ime course of virus replication as assessed by the
laque-forming assay of the tissue homogenate obtained
rom each brain region.
When the rats were infected with HSV-1 at a dose of
.0 3 104 PFU (1.5 LD50), the time profile of neurological
nd clinical signs as well as virus replication in the brain
as delayed almost 1 day during the course of the
nfection compared with the time profile for the larger
ose, 15 LD50.
xpression of iNOS mRNA in HSV-1-induced
ncephalitis
Expression of iNOS in the brain of rats after infection
ith HSV-1 at 15 LD50 was examined by using Northern
lot analysis (Fig. 2). iNOS expression was not observed
n any brain area until 4 days after infection. iNOS mRNA
as first observed apparently in the olfactory bulb and
rain stem on day 5 after infection; on day 6, strong iNOS
ction in rats, assessed by HSV-1 DNA polymerase mRNA expression
oculation of 15 LD50 HSV-1, brains were resected and the total RNA
thod was subjected to RT-PCR analysis for HSV-1 polymerase mRNA
d until 3 days after HSV-1 infection (data not shown). Similarly, the virus
CV-1 cells in culture. ND, not detected. n 5 3 for each time point andV-1 infe
nasal in
sis me
bserve
ay withnduction was observed in the olfactory bulb and brain
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Two hours after the treatment of the infected animals (ip; 100 mg/kg of D-NMM
205NO IN HERPES SIMPLEX VIRUS ENCEPHALITIStem, and moderate but significant expression of iNOS
as obtained in the cerebellum. The iNOS mRNA signal
ecame evident throughout the brain on day 7 after viral
nfection (data not shown). The time profile of iNOS
RNA expression in the brain infected with 1.5 LD50
SV-1 was similar to that for the 15 LD50-infected rats
xcept that the onset of iNOS induction in the 1.5 LD50
nfection was delayed 1 day.
The spatial and temporal patterns of iNOS mRNA ex-
ression (Fig. 2) agreed with those of virus propagation
s discussed above and shown in Fig. 1, suggesting that
NOS expression in HSV-1-infected neuronal tissue is
rought about as part of the host response to virus in
rain tissue.
O production in HSV-1-induced encephalitis
etermined by electron spin resonance (ESR)
pectroscopy
The time profile of NO production was directly mea-
ured, by using ESR spectroscopy with an NO spin
rapping agent, for the brain stem and olfactory bulb (Fig.
), where the most extensive virus invasion and iNOS
RNA expression were found (Figs. 1 and 2). NO pro-
uction, as assessed by the formation of the nitrosyl
dduct of N,N-diethyldithiocarbamate z 3H2O (DETC)–
e21, was directly identified in the brain stem and olfac-
ory bulb of HSV-1-infected rats (Fig. 3A). No appreciable
SR signal derived from the NO–DETC–Fe adduct was
bserved in rat brains obtained from normal rats andFIG. 2. iNOS mRNA expression in rat brain after HSV-1 infection. Rats
ere inoculated with HSV-1 (15 LD50), and the total RNA content was
xtracted from each brain region in the same manner as described in the
egend to Fig. 1. Northern blot analysis was performed by using a cDNA
robe for rat iNOS to examine the time course of iNOS expression in each
rain area. The level of G3PDH mRNA expression is shown as the control
ene expression in the tissue. No appreciable iNOS mRNA signal was
btained until 3 days after HSV-1 infection. (Bottom) iNOS mRNA signals
btained from three different animals were quantified by densitometric
nalysis after visualization of the hybridized membrane with Northern
lotting, using a Macintosh computer with an Image Scanner (GT6500,
pson Co., Ltd., Tokyo, Japan) and the public domain NIH Image program.hose obtained within 3 days after HSV-1 infection (15FIG. 3. Identification of NO overproduction in the HSV-1-infected brains by using ESR spectroscopy. Generation of NO was analyzed directly by ESR
pectroscopy with an NO spin trap, DETC–Fe complex. The rats were infected with 15 or 1.5 LD50 HSV-1 in the same manner as noted in the legend
o Fig. 1. (A) At each time point after HSV-1 infection (15 LD50), ESR of HSV-1-infected brain was measured at 110K by using the X-band Bruker ESR
pectrometer (ESP 380E) 30 min after DETC–Fe administration to the animals (see text for details). The ESR signal derived from NO–DETC–Fe adducts
s seen, as verified by its typical triplet hyperfine structure. (B) Effect of D-NMMA or L-NMMA treatment on NO–DETC–Fe adduct formation. ESR study
as performed in the same manner as in (A) with the brain stem of rats infected with 1.5 LD50 HSV-1 with or without D-NMMA or L-NMMA treatment.A or L-NMMA), DETC–Fe was injected, followed by ESR measurement.
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206 FUJII, AKAIKE, AND MAEDAD50). A low level of NO production was identified as
arly as day 4, although the yield of HSV-1 was still
elow the detection limit by both plaque-forming assay
nd RT-PCR analysis. Also, because iNOS mRNA was
ot detected by Northern blotting on day 4, ESR mea-
urement with use of a NO spin trap DETC–Fe complex
eems to be more sensitive than Northern blotting anal-
sis for iNOS expression in vivo. The time course of NO
roduction later than 4 days after infection was almost
arallel to that of iNOS mRNA expression and HSV-1
eplication in the olfactory bulb and the brain stem (Figs.
and 2). It is important to note that the formation of the
O–DETC–Fe adduct was almost completely nullified by
reatment of the HSV-1-infected rats (1.5 LD50) with the
OS inhibitor Nv-monomethyl-L-arginine monoacetate
alt (L-NMMA), but not with its noninhibitory enantiomer
v-monomethyl-D-arginine (D-NMMA) (Fig. 3B). These re-
ults indicate that iNOS induced in the HSV-1-infected
egion is functioning biologically to produce an exces-
ive amount of NO.
mmunohistochemical analysis for localization of
NOS-producing cells
Immunohistochemical analyses were performed to
dentify the cells expressing iNOS. In the brain stem
ection obtained 6 days after HSV-1 infection, the iNOS-
ositive cell as detected by anti-iNOS antibody was lo-
alized in the trigeminal nucleus (Fig. 4A). Also, by using
RPM-3, which is an antibody against a monocyte-de-
ived macrophage (Setoguchi et al., 1996), we found that
here was also significant inflammatory infiltration of
acrophages in the sequential section (Fig. 4B). The
orphology and distribution of iNOS-positive cells were
imilar to those of the monocyte-derived macrophages
Figs. 4A and 4B), suggesting that the monocyte-derived
acrophage was a major contributor to iNOS expression
n the HSV-1-infected lesion. However, there are a few
ells that expressed iNOS but did not stain with TRPM-3,
ndicating that iNOS expression may be attributable not
nly to the infiltrating macrophages but also to the mi-
roglia or astrocytes as reported previously (Bi et al.,
995).
Control staining for iNOS in which the first antibody
anti-iNOS) was omitted was performed with sequential
ections. No appreciable immunostaining was observed
y the control staining (Fig. 4D), whereas a positive
taining was evident in an adjacent section with this
ntibody (Fig. 4C). Similar results were obtained for
RPM-3. These data warrant unambiguously the speci-
icity of the anti-iNOS and TRPM-3 antibodies.
ffect of NOS inhibition on HSV-1 encephalitis
To clarify the role of NO produced in HSV-1-induced
ncephalitis in rats, L-NMMA was administered. Treat-
ent with L-NMMA was started at 3 days after virus pnfection, because excess NO production was induced
ater than 3 days after infection as shown in Fig. 3. The
urvival rate of rats infected with 1.5 LD50 HSV-1 was 25%
vehicle control, n 5 8), which was markedly improved to
5% by L-NMMA treatment during the observation period
f later than 10 days after infection (n 5 8, P , 0.05
ompared with the control group; Fig. 5). The lethality of
SV-1 infection was not affected appreciably by treat-
ent with D-NMMA (no significant difference was found
etween vehicle- and D-NMMA-treated groups; P .
.05).
There was no significant difference in virus yield in
ach brain region between control rats (n 5 6) and
-NMMA-treated rats (n 5 5) (Fig. 6). Although results
ere not statistically significant, L-NMMA administration
o HSV-1-infected animals tended to reduce virus prop-
gation in all sections of the brain. D-NMMA, however,
id not show any apparent effect on HSV-1 replication in
he brain (data not shown).
xpression of HO-1 mRNA in HSV-1-infected brain
HO-1 expression in HSV-1-induced encephalitis was
xamined as a marker for oxidative stress (Maines,
997). The upregulation of HO-1 mRNA, as revealed by
orthern blotting, paralleled the time profile of virus
eplication and iNOS expression, producing a high level
f NO in the HSV-1-infected brain (Fig. 7). The increase in
O-1 mRNA expression was suppressed to a great ex-
ent by L-NMMA (Fig. 8), almost to the level of nonin-
ected controls, but D-NMMA had no such suppressive
ffect (data not shown). This finding suggests that NO
ay contribute to the upregulation of HO-1, possibly
hrough exacerbation of neuronal cell damage caused by
O produced excessively during viral infection.
DISCUSSION
In the present study, the role of NO in viral pathogen-
sis was explored with experimental HSV-1-induced en-
ephalitis in rats. iNOS induction and NO overproduction
ere clearly demonstrated in the HSV-1-infected brain;
he temporal and spatial patterns of iNOS expression
ere found to be consistent with those of HSV-1 in
euronal tissues. During the infection period, iNOS in-
uction as well as virus replication in various parts of the
rain appears to spread in the following order: olfactory
ulb/brain stem 3 cerebellum 3 cerebrum. Because
he viral yield on day 5 in the olfactory bulb was higher
han that in the brain stem as assessed by both plaque-
orming assay and RT-PCR, we interpret that HSV-1 may
nter the central nervous system first through the nasal–
lfactory bulb pathway, and it can also go from the nasal
ucosa to the brain stem via the trigeminal ganglion.
he latter route of spreading is described in a previous
tudy (Beers et al., 1993). The monocyte-derived macro-
hages appeared to be a major source of iNOS expres-
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208 FUJII, AKAIKE, AND MAEDAion, which was localized mainly in the inflamed area
ith typical pathological changes due to the viral infec-
ion. Specific NOS inhibition in vivo as assessed by ESR
pectroscopy led to significant amelioration of enceph-
litis. The efficacy of NOS inhibition was substantiated
y abrogation of HO-1 mRNA upregulation, which was
riggered by HSV-1 intrusion into the brain, possibly
hrough NO overproduction. These results illustrate the
athogenic effect of excessive NO generation in HSV-1-
nduced encephalopathy in rats.
Induction of iNOS in viral infection is now well docu-
ented for a wide range of viruses (in addition to HSV-1)
hat have different organ tropisms, including neuro-,
neumo-, and cardiotropic viruses such as Borna dis-
FIG. 5. The effect of L-NMMA treatment on survival rate of rats
nfected with HSV-1. Lewis rats were infected with 1.5 LD50 HSV-1, and
-NMMA (100 mg/kg body weight) was administered ip once daily from
ay 3 to day 7 after infection. HSV-1-infected rats given only saline
erved as the control group. n 5 8 for each group; *P , 0.05 versus the
ontrol group by Fisher’s exact test.
FIG. 6. Virus yield in HSV-1-infected brain of rats with or without
-NMMA treatment. HSV-1-infected rats (1.5 LD50) received L-NMMA
reatment (100 mg/kg body weight/day; 3 to 5 days after infection) in the
ame manner as described in the legend to Fig. 5. The virus yield on
ay 6 after HSV-1 infection was quantified by using the plaque-forming
ssay with CV-1 cells in culture. The horizontal bar in the figure
ndicates the mean value of the virus yield in each brain region (n 5 5
or the control group; n 5 6 for the L-NMMA-treated group). Iase virus, human immunodeficiency virus type 1, rabies
irus, influenza virus, Sendai virus, and coxsackievirus
Koprowski et al., 1993; Zheng et al., 1993; Akaike et al.,
995, 1996; Bukrinsky et al., 1995; Kreil and Eibl, 1996;
ikami et al., 1997; Adler et al., 1997; Akaike et al.,
npublished observation).
NO has antimicrobial activity against bacteria, para-
ites, and fungi (Granger et al., 1988; Nathan and Hibbs,
991; Doi et al., 1993; James, 1995; Umezawa et al., 1997).
ome types of virus, most typically some DNA viruses
uch as a murine poxvirus (ectromelia virus) and HSV-1,
FIG. 7. Upregulation of HO-1 mRNA expression in HSV-1-infected rat
rain. HSV-1-induced encephalitis was produced by the same protocol
s noted in the legend to Fig. 1. HO-1 mRNA expression assessed by
orthern blotting with a rat HO-1 cDNA probe in rats infected with 15
D50 HSV-1.
FIG. 8. The effect of L-NMMA administration on the increased level
f HO-1 mRNA in rat brain regions (olfactory bulb and brain stem) 6
ays after infection with 1.5 LD50 HSV-1. L-NMMA (100 mg/kg body
eight) was given once daily (3 to 5 days after infection) to rats as
entioned in the legend to Fig. 5, and the level of HO-1 mRNA
xpression was determined on day 6. HO-1 mRNA signals obtained
rom two different animals (cf. paired bars) in each group were quan-
ified by densitometric analysis after visualization of the hybridized
embrane with Northern blotting, using a Macintosh computer with an
mage Scanner.
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209NO IN HERPES SIMPLEX VIRUS ENCEPHALITISre also susceptible to NO (Croen, 1993; Karupiah et al.,
993; Nathan, 1997; MacLean et al., 1998). The antiviral
ction of NO is not certain, however, for vaccinia virus
Rolph et al., 1996) and for some RNA viruses, e.g.,
nfluenza virus and Sendai virus. Also, a discrepancy
etween in vitro and in vivo action has been reported in
he effect of NO on coronavirus (mouse hepatitis virus)
eplication (Lane et al., 1997).
Overproduction of NO appears to impair physiological
unctions of the host cells nonselectively, regardless of
he direct cytopathic effect of virus replication on the host
ells. Endogenous and exogenous NO is now known to
e linked to mechanisms of apoptosis and necrosis in
arious cells including neuronal cells (Lipton et al., 1993;
ste´vez et al., 1995; Melino et al., 1997). Thus, NO may be
irectly involved in viral pathogenesis even though it
uppresses virus replication in situ (Adler et al., 1997;
kaike et al., 1998).
It is now well accepted that overproduction of NO may
ause various toxic effects possibly via formation of
otent cytotoxic NO-oxidized derivatives such as per-
xynitrite (ONOO2), which is generated by a diffusion-
imited reaction of NO and superoxide (O2
2) (Beckman
nd Koppenol, 1996; Rubbo et al., 1996). More impor-
antly, peroxynitrite per se is known to have proinflam-
atory activity, which could be exhibited through activa-
ion of cyclooxygenase (Landino et al., 1996) and matrix
etalloproteinases (Okamoto et al., 1997). We reported
reviously that NO and superoxide, and their reaction
roduct, peroynitrite, are the major pathogenic principals
n a fulminant influenza virus pneumonia in mice (Akaike
t al., 1996). It is thus of great interest to explore the
ossible role of peroxynitrite in the pathogenesis of
SV-1 encephalitis in rats, in which inflammatory re-
ponses of the hosts appear to be critically involved.
uch a study is now in progress in our laboratory, focus-
ng on the mechanism of cytotoxic and proinflammatory
ctions of NO and peroxynitrite.
In fact, our earlier study showed that a significant
mprovement in survival rate was obtained with L-NMMA
reatment of influenza virus-infected animals without im-
airment of the animals’ antiviral defense (Akaike et al.,
996). Similarly, Kreil and Eibl (1996) reported that NO
eneration does not contribute to host defense mecha-
isms against tick-borne encephalitis (TBE) virus, but
ather it seems to enhance the pathological effect of TBE
irus infection in vivo, as evidenced by the therapeutic
ffect of the NOS inhibitor aminoguanidine. Of consider-
ble importance is a recent finding by Adler et al. (1997)
hat L-NMMA treatment led to a significant improvement
f HSV-1 pneumonia as revealed by amelioration of re-
piratory dysfunction and pathological changes despite
n increase in growth of virus in the lung. This result is
onsistent with our interpretation of the role of NO in the
athogenesis of HSV-1-induced encephalitis in rats.Although an antiproliferative action of NO against bSV-1 was noted as just mentioned (Croen, 1993; Karu-
iah et al., 1993; Adler et al., 1997; Nathan, 1997; Mac-
ean et al., 1998), our present in vivo results indicate that
-NMMA suppression of excessive NO production in the
entral nervous system of HSV-1-infected animals
aused improvement in neuronal disorders, but that sup-
ression of NO generation did not influence virus prop-
gation in the nervous tissue. The beneficial effect of
OS inhibition in HSV-1-induced encephalitis may be
urther supported by the result of reduced HO-1 induction
fter treatment of HSV-1-infected rats with L-NMMA.
O-1 is known to be induced by various stimuli, such as
eactive oxygen and nitrogen species as well as hypoxia
nd heavy metals, so as to protect cells from oxidative
njury (Kim et al., 1995; Maines, 1997; Doi et al., 1998).
herefore, oxidative stress caused by overproduction of
O may contribute to the pathogenesis of HSV-1-in-
uced encephalitis. Moreover, although the effect of
-NMMA treatment on the inflammatory responses in the
SV-1 encephalitis model remains obscure, reduction of
O-1 expression by L-NMMA treatment may suggest
ndirectly an anti-inflammatory action of L-NMMA in
SV-1 encephalitis in rats, because HO-1 is also known
o be induced by various proinflammatory cytokines
Maines, 1997).
On the basis of the present results and recent evi-
ence in other published reports on viral pathogenesis
nvolving NO, it is concluded that the pathological events
n HSV-1-induced encephalitis seem to be closely linked
ot only to the direct cytopathic effect of HSV-1 but also
o NO-influenced cytotoxicity mediated by the host re-
ponses.
MATERIALS AND METHODS
irus and production of HSV-1 encephalitis
HSV-1, Fukuda strain, was used throughout the exper-
ments (Aoki et al., 1995). The virus was grown in monkey
idney epithelial cells (CV-1 cells) and was stored at
70°C until use. The experimental viral encephalitis was
roduced in male Lewis rats (SPF grade; 5 weeks old;
00–120 g body weight) by intranasal inoculation under
ight ether anesthesia at a dose of 100 ml of virus solution
t 1.0 3 105 or 1.0 3 104 PFU/ml in Dulbecco’s minimum
ssential medium (DMEM); these doses were 15 LD50
nd 1.5 LD50, respectively. All experiments were carried
ut according to the guidelines in the Laboratory Proto-
ol of Animal Handling, Kumamoto University School of
edicine.
dentification of virus replication in brain tissue
Virus was quantified by use of the plaque-forming
ssay at various time points after HSV-1 inoculation. Rats
ere exsaguinated under deep anesthesia with pento-
arbital sodium, and brain tissues were obtained. The rat
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210 FUJII, AKAIKE, AND MAEDArain was divided into four regions (olfactory bulb, brain
tem, cerebellum, and cerebrum), and each tissue was
omogenized in ice-cold 10 mM sodium phosphate-buff-
red saline (PBS; pH 7.4) containing 0.2% bovine serum
lbumin. The homogenates were then centrifuged at
0,000 g for 10 min at 4°C, followed by filtration with a
yringe filter (0.45-mm pore size; Millipore Corp., Bedford,
A). After serial dilution of the supernatant of the tissue
omogenate, aliquots were inoculated onto CV-1 cell
onolayers in culture. Cells were incubated for 3 days in
MEM containing 2% fetal bovine serum and 1% meth-
lcellulose, as described previously (Aoki et al., 1995),
fter which the number of plaques formed by virus rep-
ication was counted.
Simultaneously, HSV-1 replication in brain tissues was
etermined by use of RT-PCR for expression of mRNA of
SV-1 DNA polymerase. Specifically, after total RNA was
xtracted from the four different regions of the brain
olfactory bulb, cerebrum, cerebellum, and brain stem)
sing the guanidine thiocyanate lysis method with Trizol
eagent (Gibco BRL, Gaithersburg, MD), 0.3 mg of the
NA was subjected to RT-PCR, which was performed
ccording to the protocol described previously (Kimura
t al., 1991). The oligonucleotide primers used for HSV-1
NA polymerase were antisense 24-mer, 59-GGCGTAG-
AGGCGGGGATGTCGCG-39; sense 27-mer, 59-CAG-
ACGGCCCCGAGTTCGTGACCGGG-39. After an initial
enaturing step at 94°C, 25 PCR cycles were performed
s follows: denaturing for 45 s at 94°C, primer annealing
or 90 s at 67°C, DNA synthesis for 3 min at 72°C.
imilarly, mRNA for glyceraldehyde-3-phosphate dehy-
rogenase (G3PDH) was examined as an internal control
RNA expressed in the tissue as reported previously
Doi et al., 1996). The oligonucleotide primers used for
3PDH were antisense 20-mer, 59-CAGGGGTTTCT-
ACTCCTTG-39; sense 20-mer, 59-AAACCCATCAC-
ATCTTCCA-39.
etection of iNOS mRNA expression in the brain
iNOS expression was analyzed by Northern blotting as
escribed previously (Akaike et al., 1995; Setoguchi et al.,
996). Briefly, after electrophoresis of the total RNA (20
g) extracted from the four brain regions on formalde-
yde–agarose gel and transfer to a positively charged
ylon membrane (Hybond-N1, Amersham International
lc, Little Chalfont, England) by a capillary transfer
ethod, the membrane was hybridized with a DNA probe
or the iNOS in 53 SSPE (0.9 M NaCl, 0.05 M sodium
hosphate, and 5 mM EDTA; pH 7.7) plus 0.5% sodium
odecyl sulfate (SDS) plus 53 Denhardt’s solution plus
0 mg/ml salmon sperm DNA at 65°C. Similarly, Northern
lot analysis was performed with use of a cDNA frag-
ent for G3PDH as a control housekeeping gene in the
rain. The 32P-labeled cDNA probe for iNOS was pre-
ared by the random primer technique (Megaprime DNA fabeling system, Amersham) using a rat iNOS cDNA
ragment (297–1429) as a template (Adachi et al., 1993).
fter hybridization with the iNOS DNA probe, the mem-
rane was washed twice for 10 min in 23 SSPE plus 0.1%
DS at room temperature and twice for 20 min in 0.13
SPE plus 0.1% SDS at 65°C. The radioactive band on
he hybridized membrane was detected with a Bioimage
nalyzer (BAS2000, Fuji Photo Film, Tokyo, Japan).
mmunohistochemistry for iNOS expression
iNOS expression in rat brain was localized by immu-
ohistochemical study using a specific polyclonal anti-
ody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) for
at iNOS as reported previously (Setoguchi et al., 1996).
he brain was obtained as follows. At 6 days after HSV-1
nfection (with the 15 LD50 dose), the brain was perfused
ith 0.0375 M sodium phosphate buffer (pH 6.2) contain-
ng 0.01 M periodate, 0.075 M lysine, and 2% paraformal-
ehyde (PLP solution), and the brain was then removed
nd immersed in PLP solution for 1 h at 4°C, followed by
ehydration in sequential concentrations of sucrose. Fro-
en sections 6 mm thick were used for immunological
etection by the peroxidase–diaminobenzidine method.
fter inhibition of endogenous peroxidase activity, each
ection was incubated with the anti-rat iNOS polyclonal
ntibody for 1 h at room temperature. Sections were
ashed with PBS (pH 7.4), after which they were incu-
ated for 1 h with a sheep anti-rabbit immunoglobulin
F(ab9)2] conjugated with peroxidase diluted 1:100. Tis-
ue-bound peroxidase activity was visualized by using
,39-diaminobenzidine as a substrate; methyl green was
sed for nuclear staining. Similarly, the localization of
xudate or monocyte-derived macrophages was identi-
ied immunohistochemically by using a specific mono-
lonal antibody, TRPM-3 (Setoguchi et al., 1996).
dentification of NO production in the brain by ESR
pectroscopy
NO generation in HSV-1-infected brain was measured
irectly by ESR spectroscopy with a dithiocarbamate–
ron complex as a spin trap for NO (Akaike et al., 1996).
riefly, DETC (Wako Pure Chemical, Osaka, Japan) and
eSO4 z 7H2O were administered intramuscularly at dif-
erent sites in the lower limbs of the rats at 400 and 20
g/kg body weight, respectively. Thirty minutes after
njection of DETC and FeSO4, brains were perfused with
aline containing heparin (10 U/ml) for 5 min under pen-
obarbital anesthesia, and brains were frozen immedi-
tely in a quartz sample tube. ESR spectroscopy was
arried out by using an X-band ESR spectrometer (Bruker
SP 380E; Rheinsteten, Germany) at 110K. The condi-
ions for ESR measurement were microwave power 4
W and modulation amplitude 0.5 mT, and the magneticield was calibrated by using TCNQ-Li salt (g 5 2.00252).
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211NO IN HERPES SIMPLEX VIRUS ENCEPHALITISreatment of virus-infected rats with L-NMMA
To examine the effect of NOS inhibition on HSV-1-
nduced encephalitis, Nv-monomethyl-L-arginine mono-
cetate salt (Calbiochem–Novabiochem International,
an Diego, CA) dissolved in saline (0.5 ml) was injected
ntraperitoneally (ip) into HSV-1-infected rats at a dose of
00 mg/kg body weight/day from 3 to 7 days after viral
noculation. An enantiomer of L-NMMA, i.e., D-NMMA
A. G. Scientific, San Diego, CA), which is unable to
nhibit NOS, was administered to virus-infected rats in
he same manner as was L-NMMA. HSV-1-infected rats
iven only vehicle (saline) served as a control group.
Neurological symptoms and survival rate of HSV-1-
nfected animals were scored twice a day. The amounts
f infectious virus in rat brain tissue with or without
-NMMA treatment were determined by use of the
laque-forming assay at 6 days after infection.
Furthermore, the efficacy of NOS inhibition by L-NMMA
reatment was confirmed by ESR spectroscopy with the
ETC–Fe complex as described above. Specifically, NO
eneration in brain tissue of HSV-1-infected rats was
xamined 2 h after ip injection of L-NMMA (100 mg/kg).
xpression of HO-1 in HSV-1-infected brain
It was recently reported that NO induces upregulation
f HO-1, which is involved in heme degradation yielding
iliverdin, which exerts potent antioxidant activity under
arious oxidative stresses in biological systems (Maines,
997). Therefore, the effect of NOS inhibition was inves-
igated by analyzing the level of HO-1 mRNA expressed
n the brain during HSV-1 infection with or without
-NMMA treatment. HO-1 mRNA expression was as-
essed by Northern blotting with use of a rat HO-1 cDNA
ragment (882 bp), which was kindly provided by Dr.
higeki Shibahara, Tohoku University School of Medi-
ine, Sendai, Japan (Takeda et al., 1994). Radiolabeling of
he HO-1 cDNA probe and hybridization were done as
escribed above for the iNOS Northern blotting protocol.
tatistical analysis
Statistical difference was determined by the two-tailed
npaired t test or Fisher’s exact probability test. A P value
f , 0.05 was considered statistically significant.
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